What is Head and Neck Cancer? Types, Symptoms, and Treatment Options

What is Head and Neck Cancer?

Head and neck cancer is an umbrella term for malignancies originating from squamous cells in the tissues of the head and neck region, excluding the brain and eyes. These cancers typically begin in the moist mucosal surfaces lining the inside of the mouth, throat, and larynx, and tend to spread to surrounding tissues. Their location in an anatomically complex region is the most critical factor necessitating the management of diagnosis and treatment by specialized teams. These cellular changes can spread through regional lymphatic channels to the lymph nodes in the neck, marking a critical stage that determines the stage of the disease.

Which Organs Are Covered?

Head and neck cancers encompass a variety of organs and tissue structures that form the beginning of the upper respiratory and digestive tracts. Within this scope, structures within the oral cavity—including the tongue, gums, inner buccal mucosa, and palate—are primarily affected areas. In addition, the nasal cavity, sinuses, and the nasopharynx (the area behind the nose) are evaluated within these extensive anatomical boundaries.

The pharynx and larynx form the organ structures where this group of cancers is most frequently observed and serve as the hub of vital functions. The larynx, housing the vocal cords, and the pharynx, which connects to the esophagus, dictate the disease’s impact on both respiration and nutrition. Salivary glands are also included in this region; tumors developing in the glands under the jaw or in front of the ears are examined under this heading.

How Common Is It?

Globally, head and neck cancer cases rank sixth in frequency among all cancer types. The diagnosis of hundreds of thousands of new cases each year clearly demonstrates that this disease is a global public health issue. The incidence rises above average, particularly in populations with specific lifestyle habits and environmental exposures.

Statistical data indicate that this type of cancer is observed approximately two to three times more frequently in men than in women. However, in recent years, this gap has been narrowing due to the rise of tobacco use and viral infections among women. Although the risk increases especially in middle-aged and older individuals, an increase in the number of cases is also observed in younger age groups.

When analyzed on a regional basis, certain types are found to be more prevalent in some countries due to dietary habits and cultural factors. For instance, while oral cavity cancers are highly prevalent in some Asian countries, there is an increase in pharyngeal cancers in Western societies.

What Are the Types of Head and Neck Cancer?

The types of head and neck cancer possess a highly diverse structure classified according to the tissue type from which the tumor originates and its anatomical location. Each of these types follows a specific clinical course, and their response to treatment varies depending on their biological characteristics. Accurate classification forms the foundation for oncologists to predict the patient’s future health status and select the most effective intervention method.

Oral and Lip Cancer

Cancers developing in the oral cavity and lips are generally the easiest to detect during physical examinations, yet they progress rapidly when neglected. These malignant changes can occur at any point, starting from the outer surface of the lips and extending to the base of the tongue. In particular, the lateral borders of the tongue and the floor of the mouth are recorded in medical literature as the most susceptible areas to tumor development.

Cancers in this region mostly begin in superficial cells and can penetrate deep tissues, and even the jawbone, over time. Non-healing cracks on the lips or hardened tissues inside the mouth should be evaluated as physical reflections of the disease in its early stages. Poor oral hygiene and prostheses causing continuous trauma can also trigger risky cellular transformations in this area.

Surgical intervention usually yields highly successful results in early-detected oral and lip cancers. However, as the tumor size grows, more complex operations may be required to preserve speech, chewing, and swallowing functions. Following treatment, comprehensive rehabilitation processes are implemented to restore patients to their former state, both aesthetically and functionally.

Throat (Pharyngeal) Cancer

Throat cancer, or pharyngeal cancer in medical terms, develops in the tube-shaped structure extending from behind the nose to the beginning of the esophagus. Because this region is divided into three main parts, the exact location of the cancer is an element that fundamentally alters the treatment strategy. Tumors forming in these tissues, which encompass the nasopharynx, oropharynx, and hypopharynx, directly impact the swallowing mechanism.

Pharyngeal cancers usually have an insidious onset, and symptoms can sometimes manifest merely as a mild sensation of fullness in the throat. Cells have the potential to spread rapidly to the lymph nodes in the neck region due to the rich lymphatic network of this area. Modern imaging techniques play a vital role in determining the exact boundaries of deep-seated tumors in this region.

During the treatment process, radiotherapy and chemotherapy are frequently used as alternatives or adjuncts to surgery due to the narrow anatomical structure of the throat. Destroying the tumor without disrupting the patient’s dietary regimen is one of the primary goals emphasized by oncology teams. Target-oriented therapies applied in recent years have significantly improved survival rates in pharyngeal cancers.

Laryngeal (Voice Box) Cancer

Laryngeal cancer occurs with the deterioration of cells in the larynx, an organ located at the entrance of the windpipe that houses the vocal cords. Because it leads to a noticeable sign like hoarseness, patients often consult a doctor at an earlier stage compared to other head and neck cancers. Since even a small tumor on the vocal cords causes a perceptible change in voice in the early stages, the diagnostic process accelerates.

As the disease progresses, it can invade the cartilaginous structures of the larynx and narrow the airway, leading to severe respiratory difficulties. At this stage, treatment options may include more radical surgical interventions or intensive radiotherapy programs. Preserving the voice is considered one of the most critical success criteria for the patient’s social life in laryngeal cancer treatment.

Surgical methods in laryngeal cancers have evolved toward function-preserving techniques, where only the diseased area is removed instead of removing the entire larynx. Laser surgery and robotic methods allow patients to largely preserve their post-operative speech capabilities. Precise dose adjustments in radiation oncology also provide a significant advantage in preserving the integrity of laryngeal tissue.

Salivary Gland Cancer

Salivary glands consist of many different major and minor structures that produce the fluid that moisturizes the oral and pharyngeal region. Salivary gland cancer is most commonly seen in the parotid gland located in front of the ear, though it can also develop in the submandibular glands. This type of cancer is distinguished from other head and neck cancers due to its numerous different histological subtypes.

The tumor usually begins as a painless swelling and can grow over time, putting pressure on the facial nerve. Proximity to the facial nerve is the anatomical detail that surgeons pay the most attention and sensitivity to during the surgical planning phase. The goal of the operation is to remove the tumor within safe margins while preserving these nerves that enable facial muscle movement.

The sometimes very slow growth of salivary gland tumors can be a deceptive factor that delays patients’ process of visiting a doctor; however, even low-grade tumors carry the risk of turning into a high-grade, aggressive structure over time. Following pathological evaluation, radiotherapy planning can be performed in addition to surgery depending on the biological behavior of the tumor.

Thyroid Cancer

Thyroid cancer originates from cells in the thyroid gland, located in the lower front part of the neck, which manages the body’s metabolic rate. Examined under the title of head and neck cancer, this type is frequently diagnosed, particularly as a result of screening nodules with the help of ultrasound. Although only a very small percentage of these nodules, which are usually painless, tend to become cancerous, regular follow-up is mandatory.

The disease generally follows a slow course, and the response to treatment in many of its types is highly promising. Surgical removal of a part or the entirety of the thyroid gland is the most common and effective start of treatment. Following the surgery, an endocrinological follow-up process is meticulously carried out to maintain the patients’ hormonal balance.

In some thyroid cancer cases, radioactive iodine therapy is applied after surgery to eliminate microscopic cells remaining in the body. This method is a highly specific approach that targets only thyroid cells, causing minimal damage to healthy tissues. With interventions made at the right time, complete cure rates in thyroid cancer patients are quite high worldwide.

Nasopharyngeal Cancer

Nasopharyngeal cancer is a type that develops in the area behind the nose, close to the skull base, and is difficult to see directly during a physical examination. Due to the anatomical structure of this region, tumors are generally noticed in advanced stages through swellings in the neck lymph nodes. Genetic factors and certain viral infections have been found to play a dominant role in the development of this cancer type.

Symptoms may include non-specific signs such as unilateral ear congestion, hearing loss, and sometimes bloody nasal discharge. Because the region is difficult to access surgically, the primary treatment method for nasopharyngeal cancers is usually radiotherapy and chemotherapy. Modern radiation techniques can focus on the tumor in this region with high precision, thereby protecting surrounding brain tissues.

This type of cancer is biologically highly sensitive to radiotherapy and chemotherapy, and high control rates can be achieved even in advanced stages. Providing nutritional and oral health support to the patient during the treatment is important for managing side effects. Multidisciplinary teamwork in nasopharyngeal cancer treatment is the most important determinant for the long-term health of the patient.

What Are the Symptoms of Head and Neck Cancer?

Symptoms of head and neck cancer can initially be quite mild and misleading depending on the complexity of the region where the tumor is located. Many patients tend to delay clinical evaluation by attributing these symptoms to a seasonal infection or fatigue; however, any abnormality lasting longer than two weeks is a warning signal indicating that the cellular structure in the region needs to be examined.

Early-Stage Symptoms

Symptoms in the initial phase of head and neck cancers involve small but persistent changes occurring in the relevant area of the body. Mild hoarseness noticed in the tone of voice that does not resolve with rest is an important early warning, particularly for the laryngeal and pharyngeal regions. White (leukoplakia) or red (erythroplakia) patches forming inside the mouth can also indicate the pre-cancerous period of cells.

A non-transient foreign body sensation felt in the throat, as if something is stuck, should be taken into consideration. Small ulcers or sores inside the mouth or on the lips that do not show healing within two weeks are among the most frequently encountered symptoms of head and neck cancer. In addition, unexplained swellings forming on the gums or palate are also important for early diagnosis.

Unilateral congestion or mild pain in the ears can actually be referred pain indicating a mass in the lower parts of the throat. Small lumps in the neck that are palpable but do not cause pain can be the first physical evidence that cancer cells have reached the lymph nodes. Taking these symptoms seriously in the early stage allows the head and neck cancer treatment process to be completed with less aggressive methods.

Advanced-Stage Symptoms

As cancer cells progress into tissue depths and begin to affect nerve pathways, symptoms become much more severe and distressing. Severe pain during swallowing (odynophagia) and a sensation of food getting stuck can prevent the patient from eating, leading to rapid weight loss. Hoarseness has now turned into a distinct loss of voice, and a wheezing sound (stridor) has begun to emerge when breathing.

With the growth of tumors inside the mouth, conditions such as bad breath, blood in saliva, and teeth loosening for no apparent reason are observed. Numbness or limited mobility in a part of the face is a serious clinical picture indicating that the tumor has invaded cranial nerves. Lymph nodes in the neck region are now visible and have turned into large masses putting pressure on the skin.

In the advanced stage, patients also begin to experience systemic cancer symptoms such as constant fatigue, weakness, and loss of appetite. Limitation of jaw movements (trismus) can prevent the patient from opening their mouth fully, thereby making even the examination process difficult. At this stage, treatment aims not only to eliminate the cancer but also to alleviate the patient’s severe pain and stabilize life functions.

Which Symptoms Require Emergency Intervention?

Tumors in the head and neck region can sometimes suddenly trigger an emergency health crisis due to their proximity to vital airways and large blood vessels. A sudden worsening of shortness of breath and the patient feeling unable to get enough air is the most critical condition requiring immediate hospital admission. Sudden blockage of the airway due to tumor or edema is a life-threatening danger requiring intervention within minutes.

Uncontrollable bleeding from the mouth or nose can be an indicator that the tumor has eroded a large blood vessel, requiring emergency surgical or interventional procedures. Complete loss of swallowing function, with the patient unable to swallow even their own saliva, causing it to escape into the lungs (aspiration), is an emergency due to the risk of pneumonia. In addition, sudden loss of function in the facial region can also be a sign of acute pressure exerted by the tumor on the nervous system.

Severe head and neck pain that cannot be relieved by any medication may suggest that the tumor is progressing toward the skull base. Confusion or a sudden onset of speech disturbance should also be evaluated as a herald of a systemic crisis. Rapid interventions made in such emergencies save the patient’s life while paving the way for the healthy execution of the long-term treatment plan.

What Causes Head and Neck Cancer? Risk Factors

It is scientifically proven that lifestyle choices and environmental factors play a decisive role in the development of head and neck cancers, beyond genetic predisposition. The cancer process usually begins with accumulated damage resulting from the exposure of cells’ DNA structure to various harmful substances over many years. Knowing the risk factors is of great importance in identifying individuals who need to be monitored more carefully for prevention and early diagnosis.

Smoking and Alcohol Use

Tobacco products are accepted worldwide as the most dominant and dangerous risk factor in the development of head and neck cancers. The use of cigarettes, cigars, pipes, or hookahs releases carcinogenic substances that directly irritate the oral and pharyngeal mucosa, initiating cellular mutations. Not only smoke, but smokeless tobacco products like chewing tobacco also multiply the risk of oral cancer enormously.

Alcohol consumption acts as a catalyst that multiplies the effect of tobacco by facilitating the absorption of carcinogenic substances by tissues. In individuals who use high amounts of alcohol over a long period, the mucosal structure, especially in the pharyngeal and laryngeal regions, loses its protective feature. The combined use of alcohol and tobacco increases the risk of cancer far more than using these substances alone.

HPV Infection

Human Papillomavirus (HPV) has come to the fore of the medical world in recent years as one of the most important factors in the rise of oropharyngeal (mid-throat) cancers. High-risk types of this virus, which is usually sexually transmitted, can trigger tumor development by disrupting the control mechanisms of cells in the throat region. This virus is held responsible for a large portion of pharyngeal cancers seen in young and middle-aged individuals who do not use tobacco.

Head and neck cancers associated with HPV exhibit a different biological and clinical character than traditional tobacco-induced cancers. Such tumors generally respond better to treatments like radiotherapy and chemotherapy, and survival rates are higher. This indicates that virus-induced cancers may require a specific treatment protocol of their own.

Vaccination efforts and safe sex awareness are the most fundamental, promising prevention methods for preventing HPV-related head and neck cancers. Viral load measurement is used today as a standard evaluation in the diagnosis process and provides insight into the potential course of the disease. HPV awareness has become an indispensable part of the modern answers given to the question of what head and neck cancer is.

Genetic Predisposition and Other Factors

In some individuals, the body’s DNA repair system may be weaker due to hereditary genetic mutations. It is known that individuals with a family history of head and neck cancer may be more sensitive to environmental risks and may therefore need a more careful follow-up process; however, genetics becomes a risk factor when combined with environmental triggers rather than being a cause on its own.

Dietary habits, particularly a diet deficient in vitamins A and C, can disrupt mucosal health, paving the way for the cancer process. Within the scope of occupational exposures, workers exposed to wood dust, nickel dust, or various chemical vapors for a long time face an increased risk of nasal and sinus cancer. In addition, poor oral hygiene and chronic gum infections can also disrupt the structure of cells by creating continuous inflammation in the region.

Prolonged, unprotected exposure to sunlight (ultraviolet radiation) is one of the most significant external risk factors for lip cancers. Diseases that suppress the immune system or medications used after organ transplantation can also weaken the body’s natural fight against cancerous cells.

How Is Head and Neck Cancer Diagnosed?

The diagnostic process is a meticulous effort starting with taking a detailed history of the patient and performing a physical examination of the neck region. Physicians evaluate every detail with great care, from the smallest color change inside the mouth to the slightest stiffness in the neck. Today, diagnosis is a multi-stage process that is not limited to physical findings but is supported by advanced technological imaging and biochemical analyses.

Endoscopy and Biopsy

Endoscopic methods are the most effective diagnostic tools used to reach deep parts of the head and neck region that cannot be seen directly by the eye. With the help of a thin, flexible tube equipped with a high-resolution camera at its tip, the nasal cavity, nasopharynx, pharynx, and larynx can be examined in detail within seconds.

If a suspicious mass or tissue change is detected during the examination, performing a biopsy is inevitable for a definitive diagnosis. A biopsy is the process of taking a small tissue sample from that region and examining it under a microscope in a pathology laboratory. Without this procedure, it is medically impossible to say with certainty whether a formation is cancer or what type it is.

Biopsy findings provide the most critical information showing the structure of the tumor, its growth rate, and which treatment it might respond to best. Sometimes, a quick preliminary evaluation can also be made by taking a cell sample from swellings in the neck with the help of a thin needle (fine needle aspiration biopsy). With the completion of the pathological report, the most suitable roadmap for head and neck cancer treatment begins to be drawn.

Imaging Methods (CT, MRI, PET)

Imaging technologies determine the exact location, size, and depth relationship of the tumor diagnosed by biopsy within the body. Computed Tomography (CT) is a very effective method, particularly in showing bone tissue involvement and the pressure of the tumor on surrounding soft tissues. In scans performed using contrast media, the vascular structures feeding the tumor can also be clearly revealed.

Magnetic Resonance Imaging (MRI) is the technology that shows the complex muscle, nerve, and mucosal structures in the head and neck region with the highest detail. MRI images are of vital importance, particularly for understanding cranial nerve involvement and whether the tumor is progressing along nerve pathways. These images serve as a navigation map determining which boundaries surgeons must preserve during the operation.

Positron Emission Tomography (PET-CT) is a whole-body scanning method used to check whether there is metastasis anywhere in the body. With this method, based on the principle of high sugar consumption by cancer cells, active tumor foci in lymph nodes or distant organs can be detected.

How Is Head and Neck Cancer Treated?

Head and neck cancer treatment is a multidimensional process shaped according to the patient’s age, stage of the tumor, and biological characteristics. Today, treatment focuses not only on destroying the tumor but also on preserving vital functions such as speaking, swallowing, and aesthetic appearance.

Surgical Treatment

Surgery is based on the principle of physically removing tumors and potentially spreading lymph nodes in the head and neck region from the body. In early-stage cases, a successful surgical intervention can allow the patient to regain their health without needing another treatment. The primary goal of the surgeon here is to completely clear the cancerous tissue while causing no harm to surrounding vital organs and nerves.

Modern surgical techniques have taken on a much more closed and protective structure with the use of robotic systems and lasers. With Transoral Robotic Surgery (TORS), tumors in deep regions of the throat can be accessed through the mouth without opening a wide external incision. This both shortens the healing time and minimizes post-operative function losses.

Following the removal of large and widespread tumors, repair (reconstruction) is performed using microsurgical methods to compensate for the tissue loss in the region. These repairs, made with tissue and vascular flaps taken from another part of the body, restore the patient’s facial integrity and chewing-swallowing functions. Results from the pathological examination after surgery are the most critical document clarifying whether there is a need for additional radiotherapy or chemotherapy.

Radiotherapy

Radiotherapy is the process of targeting cancer cells with high-energy radiation beams to disrupt their DNA structure and destroy them. Within head and neck cancer treatment, radiotherapy is used sometimes as a primary alternative method to surgery, and sometimes as an adjunct to clear cells likely to remain after surgery. Due to the sensitive anatomy of the head and neck region, focusing radiation precisely on the target requires great technological expertise.

Advanced technologies such as Intensity-Modulated Radiation Therapy (IMRT) and VMAT protect critical structures like salivary glands and the spinal cord by ensuring that beams focus only on the tumor. In this way, problems like permanent dry mouth and swallowing difficulty, which are the most challenging side effects of the treatment, can be significantly reduced. Treatment is usually planned as daily sessions lasting several weeks, and nutritional support is provided to the patient during this process.

In cases like laryngeal cancer, radiotherapy is an option that can be preferred over surgery in terms of maintaining the patient’s voice quality by preserving the vocal cords. Radiation oncology specialists can update radiation doses and fields by tracking the shrinkage of the tumor during treatment. Radiotherapy shows a much stronger effect in advanced-stage tumors when combined with chemotherapy, which is a systemic treatment.

Chemotherapy

Chemotherapy is the administration of drugs that kill cancer cells or stop them from growing, given systemically to the body intravenously or orally. In head and neck cancers, chemotherapy is usually applied concurrently as a “radiosensitizing” agent to increase the effectiveness of radiotherapy. This combined treatment is a standard approach, particularly in cases that cannot be operated on or where the functional loss of surgery would be too high.

Because the drugs enter the entire body circulation, they also help clear microscopic cells outside the main tumor focus that cannot be detected by imaging methods. In advanced-stage cases, “neoadjuvant” chemotherapy applications can also be performed to reduce the size of the tumor, making it more suitable for surgery. Supportive medications used in modern oncology are highly successful in managing side effects of chemotherapy like nausea and fatigue.

Targeted Therapies and Immunotherapy

Targeted therapies are “smart” drugs that work by targeting proteins and signaling pathways that are unique or specific to cancer cells. For instance, drugs that block the Epidermal Growth Factor Receptor (EGFR), found on most head and neck cancer cells, help stop tumor growth without damaging healthy tissues. This method possesses a different side effect profile from classical chemotherapy and can better protect the patient’s quality of life.

Immunotherapy is a revolutionary type of treatment that reactivates the body’s own defense mechanism (the immune system) to recognize and destroy cancer cells. Cancer cells sometimes manage to hide from the immune system; immunotherapy drugs break this hiding mechanism, bringing the body’s natural fighters into play. Particularly in head and neck cancers that do not respond to standard treatments or recur, immunotherapy has provided striking improvements in survival times.

Head and Neck Cancer Treatment in Cuba

Cuba has become a global health destination with its unique research in medicine and biotechnology. Scientists in the country have achieved successful works for years on innovative immunotherapy drugs and vaccines aimed at stopping the growth of cancer cells. The specific molecules they have developed for head and neck cancers offer a modern alternative treatment channel for international patients.

What Is Nimotuzumab (CIMAher)?

Nimotuzumab, commercially known as CIMAher, is a targeted monoclonal antibody developed by the Center for Molecular Immunology in Cuba and widely used in head and neck cancers. This drug binds to EGFR receptors on the surface of cancer cells, cutting off their proliferation signals. The biggest difference of Nimotuzumab from its counterparts worldwide is its low toxicity on healthy tissues and therefore showing much fewer side effects.

Particularly when applied together with radiotherapy in advanced-stage pharyngeal and laryngeal cancers, this drug can accelerate the regression process of the tumor and increase the probability of keeping the disease under control. CIMAher is considered one of the most successful products of the philosophy of fighting the tumor without reducing the patients’ quality of life. Long-term clinical observations made in Cuba have revealed that this drug is an effective aid in extending patients’ lifespan.

This treatment method works by disrupting only the communication network of diseased cells without breaking the general resistance of the body. Administered periodically via the intravenous route, this protocol can be easily integrated into the patient’s general treatment plan. Nimotuzumab is one of the most important drugs representing Cuba’s biotechnological power and innovative vision in the fight against cancer.

How Does the Treatment Process Work with QBA Medi Tours?

For patients who want to gain access to these advanced technology treatments in Cuba, QBA Medi Tours offers an official and comprehensive consultancy service. The process begins with delivering the patient’s current medical reports and biopsy results from Turkey to the expert oncology committee in Cuba. Cuban doctors review these documents meticulously, evaluate the patient’s suitability for Nimotuzumab or other protocols, and issue a preliminary approval.

QBA Medi Tours lightens the burden on patients and their relatives by organizing all medical file translations, visa procedures, flight, and accommodation plans for patients who receive approval. From arrival in Cuba, patients are met at the airport and receive support at every moment through professional interpreters who will accompany them throughout the treatment. Providing the best care in modern clinics approved by the Cuban Ministry of Health and maintaining healthy doctor communication throughout the treatment process is under the guarantee of QBA Medi Tours.

When the treatment is completed and they return to Turkey, the process does not end; the healing status of the patient and ongoing medication protocols are closely followed by consultants. The continuity of treatment is ensured by establishing an information bridge between the doctors in Cuba and the process in Turkey. QBA Medi Tours guides patients to manage this challenging process in the most comfortable, transparent, and scientifically correct way.